6505--Ga68 NETSPOT Radiopharmaceuticals Corporal Michael J Crescenz VA Medical Center, Philadelphia, PA
ID: 36C24425Q0362Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF244-NETWORK CONTRACT OFFICE 4 (36C244)PITTSBURGH, PA, 15215, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for the procurement of NETSPOT Ga68 radiopharmaceuticals for the Corporal Michael J. Crescenz VA Medical Center in Philadelphia, PA. This procurement involves a firm-fixed-price contract for a 12-month period, commencing on June 4, 2025, and concluding on June 3, 2026, with a focus on supplying essential radiopharmaceuticals for imaging neuroendocrine tumors in adult patients. The selected vendor must be licensed by the Nuclear Regulatory Commission and adhere to strict delivery and regulatory standards, ensuring timely and compliant service. Interested vendors must submit their proposals by 10:00 AM EST on February 27, 2025, and can direct inquiries to Contract Specialist Christa Stine at christa.stine@va.gov or by phone at 570-824-3521.

    Point(s) of Contact
    Christa StineContract Specialist
    (570) 824-3521
    christa.stine@va.gov
    Files
    Title
    Posted
    The Corporal Michael J. Crescenz VA Medical Center is soliciting proposals for the procurement of NETSPOT Ga68 radiopharmaceuticals under solicitation number 36C24425Q0362. This Request for Quotation (RFQ) is for a firm-fixed monthly price order for a period of 12 months, starting June 4, 2025, to June 3, 2026. The contract specifies the need for a vendor licensed by the Nuclear Regulatory Commission to supply NETSPOT and associated calibration sources for nuclear medicine procedures aimed at imaging somatostatin receptor-positive neuroendocrine tumors in adult patients. The procurement falls under NAICS code 325412 and is designated as a Small Business Set-Aside. Proposals must comply with registration requirements in the System for Award Management (SAM) prior to award confirmation. The document includes the statement of work, price schedule, and past performance questionnaire as attachments. This solicitation indicates the VA's emphasis on obtaining critical medical products from authorized suppliers to support healthcare services for veterans.
    The solicitation RFQ 36C24425Q0362 from the Corporal Michael J. Crescenz VA Medical Center seeks proposals for NETSPOT Ga68 Dotatate, a commercial product/service. The government plans to award a 12-month firm-fixed-price contract, commencing June 4, 2025, and ending June 3, 2026. This Small Business Set-Aside procurement requires vendors to register in the System for Award Management (SAM) before bidding. Quotations are due by 10:00 AM EST on February 27, 2025, with inquiries accepted until February 21, 2025. Proposals must consist of four volumes: Introductory information, Price Schedule, Technical Capability, and Past Performance. Evaluation criteria prioritize price, technical capability, and past performance, allowing for comparative assessments between bids. The documentation must show compliance with specified requirements in the Statement of Work. Vendors should provide at least three references demonstrating relevant experience from the past three years. Contracting will follow provisions set forth in applicable federal regulations, ensuring transparency and integrity in the procurement process. The solicitation underscores the government's effort to engage small businesses while procuring essential medical services.
    The Corporal Michael J. Crescenz VA Medical Center (CMC VAMC) seeks a licensed vendor to supply the radiopharmaceutical NETSPOT and calibration sources for its Nuclear Medicine Service. NETSPOT, crucial for PET imaging of neuroendocrine tumors, requires timely delivery to a secured area within the facility. The contract includes stipulations for daily orders, emergency deliveries within 45 minutes, and detailed invoicing. The vendor must ensure all radiopharmaceuticals are properly labeled and adhere to regulatory standards from various organizations, including the Nuclear Regulatory Commission and the FDA. Returns for credit are allowed under specific conditions, while same-day delivery is mandated during business hours. The pricing structure is based on an as-needed basis, with all order quantities subject to change. This document outlines the project scope, expectations for quality control, and the essential processes to maintain operational efficiency at the CMC VAMC while fulfilling regulatory compliance and patient care needs. The overarching aim is to secure a reliable supply of radiopharmaceuticals that meet quality and regulatory standards for the medical center's imaging procedures.
    The document outlines the pricing structure for a federal procurement related to the supply of Ga68 NETSPOT, indicating anticipated expenditures over a 12-month contract period. The item includes a required quantity of 55 units, with pricing fields left blank for bidders to fill in. The contract period is defined, starting on June 4, 2025, and ending on June 3, 2026. This price schedule is part of a broader Request for Proposal (RFP) and aims to secure necessary supplies for government projects, aligning with federal funding regulations. The provision of this item is likely linked to healthcare or medical research, emphasizing the importance of transparency and competitive pricing in government contracts. Overall, the document serves to communicate specific procurement needs and timelines, fostering accountability in public sector purchasing.
    The Past/Present Performance Questionnaire for the Corporal Michael J Crescenz VA Medical Center is a tool used to assess contractors’ performance in fulfilling federal contracts. The document outlines the evaluator's responsibilities, including providing identifying information about the contractor and the contract, while evaluating performance across several key areas: quality of services, timeliness of performance, and business relations. Each section requires a narrative explanation alongside an adjectival rating ranging from excellent to unsatisfactory. The evaluator must also identify the contractor’s strengths and weaknesses and state whether they would choose to award the contract again. The overarching purpose of this questionnaire is to document contractor performance and facilitate informed decisions in future contractual agreements within the context of federal and state/local RFPs and grants. The structured format ensures comprehensive feedback that prioritizes effective contractor relationships and service delivery.
    Lifecycle
    Similar Opportunities
    6505--Radiopharmaceuticals Base Plus 4 Option Year IDIQ
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for an Indefinite Delivery Indefinite Quantity (IDIQ) contract for the procurement of radiopharmaceuticals, specifically Tc99m-derived products and related compounds, to be delivered to the Veterans Affairs Martinsburg Medical Center. The contract will commence on April 1, 2025, and includes a base year with four optional one-year extensions, concluding on March 31, 2030. These radiopharmaceuticals are critical for medical and diagnostic purposes within federal healthcare facilities, necessitating reliable delivery and compliance with strict safety and regulatory standards. Interested vendors must ensure they can meet the requirements for immediate orders, maintain quality control, and adhere to health regulations, with inquiries due by February 21, 2025, and responses by February 28, 2025. For further information, contact Contracting Officer Kami Hom at Kami.Hom@va.gov or by phone at 410-642-2411 x22404.
    6505--Radiopharmaceutical Delivery for VASNHCS Single Award IDIQ
    Buyer not available
    The Department of Veterans Affairs is preparing to solicit proposals for a contract titled "6505--Radiopharmaceutical Delivery for VASNHCS," aimed at providing radiopharmaceuticals to the VA Southern Nevada Healthcare System. This procurement is essential for ensuring the timely delivery of critical medical supplies necessary for patient care and treatment within the healthcare system. The solicitation is expected to be released around February 6, 2025, with quotes due by February 21, 2025, and the contract will be awarded on an unrestricted basis, allowing all responsible sources to participate. Interested contractors can reach out to Contract Specialist Mohammed Hussain at Mohammed.Hussain2@va.gov or by phone at 916-923-4534 for further information.
    Radiopharmaceuticals - Naval Medical Center Portsmouth
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is soliciting proposals for the supply of radiopharmaceuticals to the Naval Medical Center Portsmouth. The procurement aims to secure a range of unit dose radiopharmaceuticals essential for cancer patient care, including isotopes such as Tc-99m, I-123, and F-18, with specific quantities and pricing outlined for various medical applications over multiple contract periods from 2026 to 2030. These radiopharmaceuticals play a critical role in diagnostic imaging and treatment, ensuring that healthcare providers have access to necessary medical supplies for effective patient care. Proposals are due by March 11, 2025, with inquiries accepted until February 17, 2025; interested vendors should contact Carol Uebelacker at carol.e.uebelacker.civ@health.mil or call 210-952-8111 for further details.
    6505--NEW IDIQ - NON Cyclotron Radiopharmaceuticals For time period covering FY 2025 through FY 2030
    Buyer not available
    The Department of Veterans Affairs is seeking qualified vendors to provide NON-Positron Emission Tomography (PET) Radiopharmaceuticals through a new Indefinite Delivery Indefinite Quantity (IDIQ) contract for the period covering Fiscal Years 2025 through 2030. The procurement aims to secure reliable and compliant supplies of prepared single doses of radiopharmaceuticals, adhering to strict quality and regulatory standards, with an emphasis on promoting small business participation in federal procurement. These radiopharmaceuticals are critical for supporting the healthcare services provided by the VA, ensuring timely delivery and compliance with safety regulations. Interested parties should contact Contract Specialist Edward Hunter at edward.hunter@va.gov for further details regarding the solicitation and requirements.
    6505--Radiopharmaceuticals
    Buyer not available
    The Department of Veterans Affairs is seeking qualified contractors to provide radiopharmaceuticals for the Portland, OR VA Medical Center, as outlined in a Sources Sought Notice. The procurement aims to identify vendors capable of supplying a range of nuclear medicine agents, including but not limited to Technetium-99m and I-131 Sodium Iodide, with requirements for timely ordering and delivery, including same-day service for urgent requests. These radiopharmaceuticals are critical for diagnostic imaging and patient care, ensuring that the VA healthcare services can effectively meet the needs of veterans. Interested parties should contact José Ronstadt at jose.ronstadt@va.gov or call 360-852-9885 for further details, with the anticipated period of performance running from July 1, 2025, to June 30, 2030.
    6505--NEW IDIQ - NON-PET Radiopharmaceuticals For Ordering periods from FY25 through FY29
    Buyer not available
    The Department of Veterans Affairs is preparing to issue a Request for Quote (RFQ) for NON-Positron Emission Tomography (PET) Radiopharmaceuticals intended for the VA Palo Alto Healthcare System. This procurement will cover ordering periods from Fiscal Year 2025 through Fiscal Year 2029 and is categorized under NAICS code 325412, emphasizing the importance of specialized radiopharmaceuticals in providing healthcare services to veteran patients. The RFQ is an open market solicitation aimed at awarding a single firm-fixed price contract, with solicitation documents expected to be available around February 14, 2025, and responses due by 12:00 PM Pacific Time on February 28, 2025. Interested parties can direct inquiries to Contracting Officer Edward Hunter at edward.hunter@va.gov or by phone at (702) 791-9000.
    6525--DEC 2024 Equipment Only Consolidation
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of medical equipment under the solicitation titled "6525--DEC 2024 Equipment Only Consolidation." This initiative aims to acquire high-tech medical imaging equipment, specifically targeting the needs of the National Acquisition Center (NAC) for various healthcare facilities serving veterans. The procurement process is crucial for enhancing healthcare services, ensuring that the VA can provide state-of-the-art diagnostic and treatment capabilities. Key deadlines include the submission of vendor questions by February 19, 2025, and the final offer submission due by April 9, 2025. Interested vendors should direct inquiries to Contract Specialist Hermann A. Degbegni at hermann.degbegni@va.gov for further details.
    6505--Tamsulosin Capsules
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Tamsulosin Hydrochloride capsules as part of its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing for a base year and four option years, ensuring compliance with FDA standards and providing a unique 11-digit National Drug Code (NDC) for each product. This procurement is vital for maintaining a consistent supply of necessary pharmaceuticals to federal healthcare facilities, adhering to regulatory standards while ensuring availability and pricing stability. Interested parties must submit their offers by February 24, 2025, at 2:30 PM CST, and can contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further information.
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Rituximab 10mg/ml and its biosimilars, aimed at establishing a reliable pharmaceutical supply source for government healthcare facilities. Bidders are required to provide unique National Drug Code (NDC) numbers for their products and include a 0.5% Cost Recovery Fee in their pricing, with the contract covering a base year and four optional subsequent years. This procurement is critical for ensuring consistent product availability and pricing based on estimated annual usage, while adhering to FDA regulations and the Drug Supply Chain Security Act (DSCSA) for safety and traceability. Interested suppliers must submit their proposals by March 11, 2025, at 2:30 PM CT, and can contact Contract Specialist Deborah S Fassl at Deborah.Fassl@va.gov for further information.
    6505--Mycophenolate Mofetil RFP
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Mycophenolate Mofetil capsules and tablets under Solicitation Number 36E79725R0010, aimed at establishing national pricing for these pharmaceutical products. The contract is intended to support various government health care facilities, including those under the Department of Defense and Indian Health Service, ensuring compliance with FDA standards and the Drug Supply Chain Security Act. Offerors are required to submit pricing for both the base year and four option years, with a deadline for submissions extended to March 4, 2025, at 2:30 PM CST, and must acknowledge receipt of this amendment to avoid rejection of their offers. Interested parties can contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further information.